<DOC>
	<DOCNO>NCT01906008</DOCNO>
	<brief_summary>The goal clinical research study learn minocycline reduce numbness , pain , and/or loss motor function patient colorectal cancer . In study , minocycline compare placebo . The study doctor explain study drug design work . A placebo drug . It look like study drug , design treat disease illness . It design compare study drug learn study drug real effect .</brief_summary>
	<brief_title>Phase II Study Minocycline Reducing Symptom Burden Colorectal Patients</brief_title>
	<detailed_description>Nearly 40 % patient colorectal cancer receive oxaliplatin-based chemotherapy experience neuropathy ( nerve damage include numbness , pain , and/or loss motor function ) . Sometimes , nerve damage serious enough chemotherapy dose lower stop completely . Researchers want find take minocycline low side effect cause chemotherapy give treat colorectal cancer . Study Groups : If agree take part study , randomly assign ( flip coin ) 1 2 group . You equal chance either group : - If Group 1 , take placebo . - If Group 2 , take minocycline . Neither study staff know receive study drug placebo . However , need safety , study staff able find receiving . Study Drug Administration : Starting Day 1 Cycle 1 chemotherapy , start take study drug/placebo capsule mouth , twice day every day . You take study drug/placebo full glass ( 8 ounce ) water . You may take without food , cause upset stomach , take food . You lie least 30 minute take study drug/placebo reduce risk side effect . Study Visits : Before start take study drug/placebo : - You complete 4 questionnaire pain symptom , quality life . You also complete questionnaire tobacco history . It take 15-25 minute complete questionnaire . - You may complete sensory test . For test , researcher try find sensitive touching thing small bump board . This test take 10 minute complete . - If possible , blood ( 6 teaspoon ) draw test marker inflammation . Markers inflammation find blood may relate symptom . 1 time week : - You complete questionnaire clinic telephone symptom may may affect daily activity . The questionnaire take 3-5 minute complete time . At chemotherapy cycle : - You fill 2 questionnaire clinic telephone pain symptom . It take 10-15 minute complete questionnaire . - The study staff make count number pill take far . If coming MD Anderson Harris Health clinic , bring study drug/placebo container ( along remain drug/placebo ) . At 2 month : - If return MD Anderson Harris Health clinic visit , follow additional procedure perform : - If possible , blood ( 6 teaspoon ) draw test marker inflammation . You may complete sensory test . This test take 10 minute complete . End-of-Treatment Visit ( 4 month ) : - You fill 4 questionnaire clinic telephone symptom . It take 15-20 minute complete questionnaire . - The study staff make count number pill take far . If return MD Anderson Harris Health clinic visit : - If possible , blood ( 6 teaspoon ) draw test marker inflammation . - You may complete sensory test . This test take 10 minute complete . - You must bring study drug/placebo container ( along remain drug/placebo ) . Length Study : You may continue take study drug/placebo 4 month , treatment delay . You longer able take study drug disease get bad , intolerable side effect occur , unable follow study direction . Your participation study End-of-Study visit . End-of-Study Visit : At 6 month , follow test procedure perform : Â°You fill 4 questionnaire clinic telephone pain symptom quality life . You also complete questionnaire tobacco history . It take 15-25 minute complete questionnaire . If return MD Anderson Harris Health clinic visit : - If possible , blood ( 6 teaspoon ) draw test marker inflammation . - You may complete sensory test . This test take 10 minute complete . This investigational study . Minocycline FDA approve commercially available treatment bacterial infection . Its use study investigational . Up 166 participant enrol study . Up 83 enrolled Harris Health System .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>1 . Patients pathologically proven diagnosis CRC see either MD Anderson LBJ . 2 . Patients &gt; = 18 year old . 3 . Patients qualify oxaliplatinbased chemotherapy ( adjuvant metastatic setting ) likely receive least 3 month oxaliplatin . 4 . Patients speak English Spanish ( due language option MDASI version use study , recruit Englishspeaking Spanishspeaking patient ) . 5 . Patients NCICTCv4 sensory neuropathy score 0 . 6 . Patients adequate renal function ( serum creatinine must &lt; 1.5 time upper limit institutional normal range ) prior renal disease opinion attend physician would make patient ineligible receive study drug . Test result must 3 month old . 7 . Patients adequate hepatic function ( total bilirubin must &lt; 2.0 time upper limit institutional normal range ; alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) must &lt; 3.0 time upper limit institutional normal range ) . Test result must 3 month old . 8 . Patients willing able review , understand , provide write consent . 1 . Patients continuously take minocycline within last 15 day . Patients condition potentially preclude use minocycline determine treat physician . 2 . Patients continuously take systemic steroid within last 15 day . 3 . Patients autoimmune disorder ( example , systemic lupus erythematosus rheumatoid arthritis ) , treat last 3 year . 4 . Patients pregnant ; absence pregnancy confirm negative urine test . 5 . Hypersensitivity tetracycline , history allergy drug reaction treat physician 's judgment make patient inappropriate study . 6 . Patients receive vitamin K antagonist ( warfarin ) . 7 . Patients BMI &gt; 40 ( Obese Class III criterion ) . 8 . Patients receive cetuximab target therapy physician may use topical doxycycline reduce rash associate therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Colorectal cancer</keyword>
	<keyword>CRC</keyword>
	<keyword>Acute peripheral neuropathy</keyword>
	<keyword>Numbness</keyword>
	<keyword>Pain</keyword>
	<keyword>Loss motor function</keyword>
	<keyword>Minocycline</keyword>
	<keyword>Dynacin</keyword>
	<keyword>Minocin</keyword>
	<keyword>Minocin PAC</keyword>
	<keyword>Myrac</keyword>
	<keyword>Solodyn</keyword>
	<keyword>Placebo</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Sensory test</keyword>
</DOC>